Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-mefloquine for uncomplicated P. falciparum malaria in Thailand
NCT02052323Phase 4Completed
- Sponsor
- Armed Forces Research Institute of Medical Sciences
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate, mefloquine in malaria, sponsored by Armed Forces Research Institute of Medical Sciences. Started Oct 2013; status: completed.
02
Drugs
artesunatemefloquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02052323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052323.